Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02612376 · ClinicalTrials.gov registry record
Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 800
- Enrollment target
NCT02612376 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 800 participants.
The verdict
NCT02612376 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 800 participants
- Enrollment target
Study Summary
This study plans to establish a large bank of blood, cerebral spinal fluid (CSF), imaging, and clinical data. These data and samples will be used for future research into the causes of Alzheimer's disease (AD), Down Syndrome (DS) and other diseases that cause thinking and memory problems. This future research will also study how treatments for these diseases work. This research may help develop new treatments for some diseases of the nervous system and help understand these diseases better.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2016-02 |
| Est. Completion | 2025-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02612376
The ClinicalTrials.gov registry entry for NCT02612376 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02612376 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02612376 about?
NCT02612376 is a clinical study titled "Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study". This study plans to establish a large bank of blood, cerebral spinal fluid (CSF), imaging, and clinical data. These data and samples will be used for future research into the causes of Alzheimer's disease (AD), Down Syndrome (DS) and other diseases that cause thinking and memory problems. This futur...
What is the current status of trial NCT02612376?
This trial is currently terminated. The enrollment target is 800 participants. The study started on 2016-02. Estimated completion is 2025-05.
Who is sponsoring clinical trial NCT02612376?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.